Development, optimization, and evaluation of PEGylated brucine-loaded PLGA nanoparticles

References

• Ahmed A, Saleh A, Shaaban O. (2015). Gold nanoparticles decorated with octreotide for somatostatin receptors targeting. J Pharm Sci Res 7:14–20.
   PubMedGoogle Scholar
• Budhian A, Siegel SJ, Winey KI. (2007). Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content. Int J Pharm 336:367–75.
   PubMed Web of Science ®Google Scholar
• Catarina PR, Ronald JN, Antonio JR, Francisco V. (2006). Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomed Nanotechnol Biol Med 2:8–21.
   PubMed Web of Science ®Google Scholar
• Danaei M, Dehghankhold M, Ataei S, et al. (2018). Impact of particle size and Polydispersity Index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics 10:57–17.
   PubMed Web of Science ®Google Scholar
• Dos S, da S, Pereira-Filho E, et al. (2012). Polymeric nanoparticles loaded with the 3,5,3-triiodothyroacetic acid (Triac), a thyroid hormone: factorial design, characterization, and release kinetics. Nanotechnol Sci Appl 5:37–48.
   PubMedGoogle Scholar
• Erfaneh G, Jaleh V, Ali J, et al. (2018). Pharmacokinetics and in vitro/in vivo antitumor efficacy of aptamer-targeted Ecoflex® nanoparticles for docetaxel delivery in ovarian cancer. Int J Nanomed 2018:493–504.
   Google Scholar
• George M, Era T, Sylva H, et al. (2009). In vivo investigation of tolerance and antitumor activity of cisplatin-loaded PLGA-mPEG nanoparticles. Eur J Pharm Biopharm 71:190–5.
   PubMed Web of Science ®Google Scholar
• Govender J, Stolnik S, Garnett M, Illum L. (1999). PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Control Release 57:171–85.
   PubMed Web of Science ®Google Scholar
• Gupta A, Chaphalkar S. (2015). Cytotoxic and anti-inflammatory activity of aqueous extract of Strychnosnux-vomica. J Biol Nat 4:217–23.
   Google Scholar
• Hoa L, Nguyen T, Le H, Dang M. (2012). Preparation and characterization of nanoparticles containing ketoprofen and acrylic polymers prepared by emulsion solvent evaporation method. J Exp Nanosci 7:189–97.
   Web of Science ®Google Scholar
• Ismail R, Sovány T, Gácsi A, et al. (2019). Synthesis and statistical optimization of poly (lactic-co-glycolic acid) nanoparticles encapsulating GLP1 analog designed for oral delivery. Pharm Res 36:1–16.
   Web of Science ®Google Scholar
• Issa A, Mohammad R, Motahare-Sadat H. (2013). Anticancer activity of nanoparticles based on PLGA and its co-polymer: in-vitro evaluation. Iran J Pharm Res 12:623–34.
   PubMed Web of Science ®Google Scholar
• Jiang W, Kim B, Rutka J, Chan W. (2007). Advances and challenges of nanotechnology-based drug delivery systems. Expert Opin Drug Deliv 4:621–33.
   PubMed Web of Science ®Google Scholar
• Jörg K, Telli H, Sebastian D, et al. (2007). Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain. J Control Release 118:54–8.
   PubMed Web of Science ®Google Scholar
• Keum c, Young-Wook N, Jong-suep B, et al. (2011). Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid. Int J Nanomedicine 6:2225–34.
   PubMed Web of Science ®Google Scholar
• Kozaki M, Kobayashi SI, Goda Y, et al. (2017). Evaluating the properties of poly(lactic-co-glycolic acid) nanoparticle formulations encapsulating a hydrophobic drug by using the quality by design approach . Chem Pharm Bull 65:218–28.
   PubMed Web of Science ®Google Scholar
• Lee E, Na K, Bae Y. (2005). Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. J Control Release 103:405–18.
   PubMed Web of Science ®Google Scholar
• Lövestam G, Rauscher H, Roebben G, et al. (2010). Considerations on a definition of nanomaterial for regulatory purposes. Luxembourg: Publications Office of the European Union.
   Google Scholar
• Lucia R, Ioan T, Marcela A, Laurian V. (2015). Development and optimization of quercetin loaded PLGA nanoparticles by experimental design. Clujul Medical 88:214–23.
   PubMedGoogle Scholar
• Mehrotra A, Pandit JK. (2012). Critical process parameters evaluation of modified nanoprecipitation method on lomustine nanoparticles and cytostatic activity study on L132 human cancer cell line. J Nanomed Nanotechnol 3:6.
   Google Scholar
• Moacir RF, SKC d, da SM, et al. (2012). Polymeric nanoparticles loaded with the 3,5,3-triiodothyroacetic acid (Triac), a thyroid hormone: factorial design, characterization, and release kinetics. Nanotechnol Sci Appl 2012:37–48.
   Google Scholar
• Mohamed F, Nicolas A, Justine W, et al. (2019). An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites. J Pharm Pharmacol 71:1185–1198.
   PubMed Web of Science ®Google Scholar
• Mohammed H, Urszula D. (2014). PLGA biodegradable nanoparticles containing perphenazine or chlorpromazine hydrochloride: effect of formulation and release. Int J Mol Sci 15:23909–23.
   PubMed Web of Science ®Google Scholar
• Morsy MA, Abdel-Latif RG, Nair AB, et al. (2019). Preparation and evaluation of atorvastatin-loaded nanoemulgel on wound-healing efficacy. Pharmaceutics 11:609.
   PubMed Web of Science ®Google Scholar
• Navneet S, Parshotam M, Senshang L. (2016). Effect of process and formulation variables on the preparation of parenteral paclitaxel-loaded biodegradable polymeric nanoparticles: a co-surfactant study. Asian J Pharm Sci 11:404–16.
   Web of Science ®Google Scholar
• Nazimuddin C, Satveer J, Dinesh D, et al. (2019). Preparation, optimization, and in vivo evaluation of nanoparticle-based formulation for pulmonary delivery of anticancer drug. Medicina 55: 294.
   PubMedGoogle Scholar
• Ogawara K, Un K, Minato K, et al. (2008). Determinants for in vivo anti-tumor effects of PEG liposomal doxorubicin: importance of vascular permeability within tumors. Int J Pharm 359:234–40.
   PubMed Web of Science ®Google Scholar
• Patel B, Gupta V, Ahsan F. (2012). PEG-PLGA based large porous particles for pulmonary delivery of a highly soluble drug, low molecular weight heparin. J Control Release 162:310–20.
   PubMed Web of Science ®Google Scholar
• Pedram R, Azita H. (2017). Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and bio distribution profile. Int J Nanomed 12:935–47.
   PubMed Web of Science ®Google Scholar
• Peng Y, Nie J, Cheng W, et al. (2018). A multifunctional nanoplatform for cancer chemo-photothermal synergistic therapy and overcoming multidrug resistance. Biomater Sci 6:1084–98.
   PubMed Web of Science ®Google Scholar
• Prakash C, Amita V, Fahad A, et al. (2017). Development of surface-engineered PLGA nanoparticulate-delivery system of Tet1-conjugated nattokinase enzyme for inhibition of Aβ40 plaques in Alzheimer’s disease. Int J Nanomed 12:8749–68.
   PubMed Web of Science ®Google Scholar
• Qin J, Pei-Hao Y, Qi L, et al. (2012). Anti-tumor effects of brucine immuno-nanoparticles on hepatocellular carcinoma. Int J Nanomed 7:369–79.
   PubMed Web of Science ®Google Scholar
• Rao JP, Geckeler KE. (2011). Polymer nanoparticles: preparation techniques and size-control parameters. Prog Polym Sci 36:887–913.
   Web of Science ®Google Scholar
• Ravi K, Bakowsky U, Lehr CM. (2004). Preparation and characterization of cationic PLGA nanospheres as DNA carriers. Biomaterials 25:1771–7.
   PubMed Web of Science ®Google Scholar
• Rekha K, Jyoti S, Vinay S. (2014). Development and characterization of nanoparticles for the delivery of gemcitabine hydrochloride. Sci World J 2014:1–6.
   Google Scholar
• Rizwan K, Muhammad A, Sarfaraz K, et al. (2019). The influence of ionic and nonionic surfactants on the colloidal stability and removal of CuO nanoparticles from water by chemical coagulation. Int J Environ Res Public Health 16:1–17.
   Web of Science ®Google Scholar
• Rodríguez A, Batlle R, Nerín C. (2007). The use of natural essential oils as antimicrobial solutions in paper packaging. Part II. Prog Org Coat 60:33–8.
   Web of Science ®Google Scholar
• Rubiana M, Maria P, Raul C. (2006). Thermoanalytical study of praziquantel-loaded PLGA nanoparticles. Braz J Pharm Sci 42:523–30.
   Google Scholar
• Sempf K, Tabiwang A, Svetlana G, et al. (2013). Adsorption of plasma proteins on uncoated PLGA nanoparticles. Eur J Pharm Biopharm 85:53–60.
   PubMed Web of Science ®Google Scholar
• Shah J, Nair AB, Jacob S, et al. (2019). Nanoemulsion based vehicle for effective ocular delivery of moxifloxacin using experimental design and pharmacokinetic study in rabbits. Pharmaceutics 11:230.
   PubMed Web of Science ®Google Scholar
• Shehata T, Ken-ichi O, Kazutaka H, Toshikiro K. (2008). Prolongation of residence time of liposome by surface-modification with mixture of hydrophilic polymers. Int J Pharm 359:272–9.
   PubMed Web of Science ®Google Scholar
• Shehata T, Toshikiro K, Kazutaka H, Ken-ichi O. (2016). In-vivo disposition characteristics of PEG niosome and its interaction with serum proteins. Int J Pharm 512:322–8.
   PubMedGoogle Scholar
• Shu L, Xi-Peng W. (2017). In vitro and in vivo evaluation of novel NGR-modified liposomes containing brucine. IJN 12:5797–804.
   Google Scholar
• Siqi Y, Linzhu Z, Yue S, et al. (2019). One-pot photoreduction to prepare NIR-absorbing plasmonic gold nanoparticles tethered by amphiphilic polypeptide copolymer for synergistic photothermal-chemotherapy. Chin Chem Lett 30:187–91.
   Web of Science ®Google Scholar
• Song X, Zhao Y, Hou S, et al. (2008). Dual agents loaded PLGA nanoparticles: systematic study of particle size and drug entrapment efficiency. Eur J Pharm Biopharm 69:445–53.
   PubMed Web of Science ®Google Scholar
• Sovan LP, Utpal J, Manna PK, et al. (2011). Nanoparticle: an overview of preparation and characterization. J Appl Pharm Sci 01:228–34.
   Google Scholar
• Tefas LR, Tomuţă I, Achim M, Vlase L. (2015). Development and optimization of quercetin-loaded plga nanoparticles by experimental design. Clujul Med 88:214–23.
   PubMedGoogle Scholar
• Venkatasubbu G, Ramasamy S, Avadhani G, et al. (2013). Surface modification and paclitaxel drug delivery of folic acid modified polyethylene glycol functionalized hydroxyapatite nanoparticles. Powder Technol 235:437–42.
   Web of Science ®Google Scholar
• Vuddanda PR, Mishra A, Singh SK, Singh S. (2015). Development of polymeric nanoparticles with highly entrapped herbal hydrophilic drug using nanoprecipitation technique: an approach of quality by design. Pharm Dev Technol 20:579–87.
   PubMed Web of Science ®Google Scholar
• Wang Y, Puwang L, Lingxue K. (2013). Chitosan-modified PLGA nanoparticles with versatile surface for improved drug delivery. AAPS PharmSciTech 14:585–92.
   PubMed Web of Science ®Google Scholar
• Xiao LN, Long XC, Heng Z, et al. (2017). In vitro and in vivo antitumor effect of gefitinib nanoparticles on human lung cancer. Drug Deliv 24:1501–12.
   PubMed Web of Science ®Google Scholar
• Xiaowei Z, Wei T, Zhongyuan W, et al. (2015). Docetaxel-loaded nanoparticles of dendritic amphiphilic block copolymer H40-PLA- b -TPGS for cancer treatment. Part Part Syst Charact 32:112–22.
   Web of Science ®Google Scholar
• Yang R, Han X, Shia X, et al. (2009). Cationic formulation of paclitaxel-loaded poly D, L-lactic-co-glycolic acid (PLGA) nanoparticles using an emulsion-solvent diffusion method. Asian J Pharm Sci 4:89–95.
   Google Scholar
• Yuan B, Mingjiang Y, Xiao W, et al. (2018). Antitumor activity of arsenite in combination with tetrandrine against human breast cancer cell line MDA-MB-231 in vitro and in vivo. Cancer Cell Int 18:113–4.
   PubMed Web of Science ®Google Scholar
• Zhipeng Chen J, Wu L, Li W, et al. (2013). Hyaluronic acid-coated bovine serum albumin nanoparticles loaded with brucine as selective nanovectors for intra-articular injection. Int J Nanomed 8:3843–53.
   PubMed Web of Science ®Google Scholar
• Zili Z, Sfar S, Fessi H. (2005). Preparation and characterization of poly-epsilon-caprolactone nanoparticles containing griseofulvin . Int J Pharm 294:261–7.
   PubMed Web of Science ®Google Scholar